Chemoinformaics analysis of 2,3 dihroxypropyl linoleate
| Molecular Weight | 354.531 | nRot | 17 |
| Heavy Atom Molecular Weight | 316.227 | nRig | 3 |
| Exact Molecular Weight | 354.277 | nRing | 0 |
| Solubility: LogS | -4.671 | nHRing | 0 |
| Solubility: LogP | 5.909 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 63 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 38 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 63.6161 |
| nHD | 2 | BPOL | 40.7259 |
| QED | 0.226 |
| Synth | 2.973 |
| Natural Product Likeliness | 1.322 |
| NR-PPAR-gamma | 0.843 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.825 |
| HIA | 0.021 |
| CACO-2 | -4.624 |
| MDCK | 0.0000441 |
| BBB | 0.186 |
| PPB | 0.96842 |
| VDSS | 0.75 |
| FU | 0.0238201 |
| CYP1A2-inh | 0.653 |
| CYP1A2-sub | 0.133 |
| CYP2c19-inh | 0.283 |
| CYP2c19-sub | 0.056 |
| CYP2c9-inh | 0.527 |
| CYP2c9-sub | 0.897 |
| CYP2d6-inh | 0.018 |
| CYP2d6-sub | 0.074 |
| CYP3a4-inh | 0.723 |
| CYP3a4-sub | 0.069 |
| CL | 10.556 |
| T12 | 0.689 |
| hERG | 0.081 |
| Ames | 0.207 |
| ROA | 0.01 |
| SkinSen | 0.963 |
| Carcinogencity | 0.375 |
| EI | 0.095 |
| Respiratory | 0.293 |
| NR-Aromatase | 0.754 |
| Antiviral | Yes |
| Prediction | 0.79371 |